ArticleGenes2022

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment.

Ari Raphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.